GlassScriptPhysician profile
Beth Schumacher
NPI 1649739095
$804.72
in general payments reported to CMS, 2019-2025
13 companies · $471 in 2025
The $471 reported for 2025 was more than what 91% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.11 · 2023: $55.20 · 2024: $224 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $174.00 | 2025 | Surgicount |
| Merck Sharp & Dohme LLC | $101.89 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Abbvie INC. | $85.23 | 2024-2025 | |
| Sanofi Pasteur INC. | $73.04 | 2022-2025 | |
| Novo Nordisk INC | $69.52 | 2022-2025 | Wegovy |
| Glaxosmithkline, LLC. | $69.38 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Radius Health, INC. | $63.58 | 2024-2025 | Tymlos |
| Seqirus USA INC | $62.51 | 2022-2024 | Flucelvax, Fluad |
| Phathom Pharmaceuticals, INC. | $33.18 | 2024 | Voquezna |
| Ironshore Pharmaceuticals INC. | $21.15 | 2023 | Jornay Pm |
| Lilly USA, LLC | $20.00 | 2024 | Jardiance |
| Amgen INC. | $17.64 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $13.60 | 2025 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Schumacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.